while the pancreozymin-secretin test was abnormal in 96 % of patients with pancreatolithiasis and in 86 % of those with pancreatic carcinoma , the pancreatic dmo excretion test gave abnormal results in 100 % of the patients .
C0235974
of
C0030274
pancreatic